SANA — SANA BIOTECHNOLOGY INC

Ownership history in D.A. DAVIDSON & CO.  ·  7 quarters on record

This page tracks every 13F SEC filing in which D.A. DAVIDSON & CO. reported a position in SANA BIOTECHNOLOGY INC (SANA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 11,220 -2,000 -15.1% 0.00% $40K $3.55
2025 Q2 REDUCED 13,220 -1,480 -10.1% 0.00% $36K $2.73
2025 Q1 UNCHANGED 14,700 — 0% 0.00% $25K $1.68
2024 Q4 REDUCED 14,700 -16,880 -53.5% 0.00% $24K $1.63
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SANA price (monthly, adj. close)

Other funds also holding SANA

As of 2025 Q4 — sorted by position size

Flagship Pioneering, LLC 3Y 7Y 31.4% Crestline Management, LP 3Y 7Y 9.32% Omega Fund Management, LLC 3Y 7Y 1.2% GREAT POINT PARTNERS LLC 3Y 7Y 0.92% Integral Health Asset Management, LLC 3Y 0.61% Alphabet Inc. 3Y 0.44% Palumbo Wealth Management LLC 3Y 0.12% ArrowMark Colorado Holdings LLC 3Y 7Y 0.06% Modus Advisors, LLC 3Y 0.06% Virtus Investment Advisers, LLC 3Y 7Y 0.06%
← Back to D.A. DAVIDSON & CO. Holdings